Steve Lasater
Family Medicine · Saint Johns, MINPI 1619930674
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $287,523 of the $290,662 with a category attached, or 98.9%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 91.6% of it on its own, with 11 other manufacturers making up the rest. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $1660.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$266K
- Shire North American Group Inc$23K
- Esperion Therapeutics, Inc.$390
- Amarin Pharma, Inc.$366
- Amgen$141
- Novo Nordisk$121
- plus $226 from 6 others
What the payments were for
- Consulting fees$287,52399%
- Travel & lodging$1,8951%
- Food & beverage$1,2260%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 140 | $266,210 |
| Shire North American Group Inc | 12 | $23,208 |
| Esperion Therapeutics, Inc. | 6 | $390 |
| Amarin Pharma, Inc. | 6 | $366 |
| Amgen | 2 | $141 |
| Novo Nordisk | 2 | $121 |
| Xeris Pharmaceuticals, Inc. | 1 | $119 |
| AbbVie | 2 | $37 |
| Lilly USA, LLC | 1 | $21 |
| IBSA Pharma Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$290,662 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 87 | $10,457 |
| Repatha SyringeEvolocumab | 12 | $6,147 |
| Armour ThyroidThyroid,pork | 11 | $1,071 |
| Ezetimibe | 28 | $945 |
| Rosuvastatin Calcium | 43 | $885 |
| Levothyroxine Sodium | 28 | $742 |
| Pravastatin Sodium | 19 | $448 |
| Np ThyroidThyroid,pork | 12 | $426 |
| Estradiol | 11 | $368 |
| Spironolactone | 12 | $193 |
| Atorvastatin Calcium | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieArmour Thyroid | $37 | $1,07111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Saint Johns
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
- Oren MasonGrand Rapids$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.